Lazard Asset Management’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-12
| Closed | -$2K | – | 1609 |
|
|
2019
Q2 | $2K | Hold |
12
| – | – | ﹤0.01% | 1184 |
|
|
2019
Q1 | $1K | Sell |
12
-996
| -99% | -$144K | ﹤0.01% | 1138 |
|
|
2018
Q4 | $134K | Buy |
1,008
+673
| +201% | +$110K | ﹤0.01% | 895 |
|
|
2018
Q3 | $63K | Sell |
335
-195
| -37% | -$35.8K | ﹤0.01% | 942 |
|
|
2018
Q2 | $88K | Sell |
530
-67,933
| -99% | -$10.9M | ﹤0.01% | 915 |
|
|
2018
Q1 | $11.5M | Sell |
68,463
-2,378
| -3% | -$399K | 0.02% | 405 |
|
|
2017
Q4 | $11.6M | Sell |
70,841
-742,708
| -91% | -$133M | 0.02% | 415 |
|
|
2017
Q3 | $167M | Sell |
813,549
-342,268
| -30% | -$79.6M | 0.3% | 74 |
|
|
2017
Q2 | $281M | Sell |
1,155,817
-75,461
| -6% | -$17.7M | 0.53% | 51 |
|
|
2017
Q1 | $294M | Buy |
1,231,278
+57,724
| +5% | +$13.4M | 0.56% | 51 |
|
|
2016
Q4 | $246M | Sell |
1,173,554
-2,146,052
| -65% | -$445M | 0.5% | 55 |
|
|
2016
Q3 | $765M | Buy |
3,319,606
+1,178,080
| +55% | +$288M | 1.52% | 14 |
|
|
2016
Q2 | $495M | Buy |
2,141,526
+2,101,665
| +5,272% | +$485M | 1.04% | 26 |
|
|
2016
Q1 | $10.7M | Buy |
39,861
+3,025
| +8% | +$866K | 0.02% | 365 |
|
|
2015
Q4 | $11.5M | Buy |
36,836
+18,730
| +103% | +$5.58M | 0.03% | 355 |
|
|
2015
Q3 | $4.92M | Buy |
18,106
+17,886
| +8,130% | +$5.49M | 0.01% | 487 |
|
|
2015
Q2 | $66K | Sell |
220
-1,700
| -89% | -$507K | ﹤0.01% | 954 |
|
|
2015
Q1 | $570K | Buy |
1,920
+339
| +21% | +$96.7K | ﹤0.01% | 752 |
|
|
2014
Q4 | $406K | Buy |
1,581
+28
| +2% | +$7K | ﹤0.01% | 839 |
|
|
2014
Q3 | $374K | Buy |
+1,553
| New | +$348K | ﹤0.01% | 769 |
|
|
2014
Q2 | – | Sell |
-1,512
| Closed | -$311K | – | 1088 |
|
|
2014
Q1 | $311K | Sell |
1,512
-5,835
| -79% | -$1.16M | ﹤0.01% | 779 |
|
|
2013
Q4 | $1.23M | Buy |
+7,347
| New | +$1.15M | ﹤0.01% | 686 |
|
Other funds holding AGN
CS
LP
FCM
